Aptevo Therapeutics Inc. Increase (Decrease) in Restricted Cash for Operating Activities
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Restricted Cash for Operating Activities of $400.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2018-03-13
- Aptevo Therapeutics Inc. increase (decrease) in restricted cash for operating activities for fiscal 2016 was $400.00K.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|
| 2016-12-31 | $400.00K 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |